Galderma Agrees to Buy ZO Skin Health for $1.5 Billion
Galderma Group agreed to buy ZO Skin Health from Blackstone, the Obagi family and other shareholders for $1.5 billion, including debt, to expand its premium skincare portfolio.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Galderma agrees to buy ZO Skin Health for USD 1.5 billion
Galderma agreed to buy physician-dispensed skincare brand ZO Skin Health for an enterprise value of USD 1.5 billion in cash. Deal expected to close in Q4 2026 or early 2027, subject to customary closing conditions. ZO Skin Health recorded about USD 330 million net sales in the 12 months ended June 2026. Purchase to be
Galderma Agrees to Buy ZO Skin Health for About $1.5 Billion
Galderma has agreed to acquire ZO Skin Health for around $1.5 billion, according to two people familiar with the matter. The deal could be announced in the coming days.